As a Miami defective drug lawyer who has helped those injured by dangerous prescription drugs for nearly twenty years; I strongly urge the FDA to immediately pull diabetes drug Avandia from the U.S. market. Avandia, made by GlaxoSmithKline PLC to treat Type 2 diabetes has been linked to increased heart-attack risk.
This is a defining moment for the FDA, the Obama Administration and the safety of Americans who depend on both to protect them from dangerous prescription drugs like Avandia. Avandia’s problems began in 2007, when studies began linking to a 43% increased heart-attack risk. Since then, more studies have indicated sizable risks for cardiovascular issues. Yet, this drug remains on the market. If the risk of a drug outweighs its potential benefits, there is no reason that it should remain on the market.
I recommend anyone taking Avandia to immediately consult with your physician and consider alternative medications such as Actos. We are committed to holding drug manufacturers responsible for putting Americans in danger.
